Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

872
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
872
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

17.0K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
17.0K
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

603
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
603

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reimagining Medical Educator Development: A Mixed-Methods Evaluation of KinetiC3, A Longitudinal, Character-Integrated Teaching Academy.

Southern medical journal·2026
Same author

Clinical, Genetic, and Pathologic Variability in Myelodysplastic Syndromes and Precursor Conditions Across Race, Ethnicity, and Sex.

American journal of hematology·2026
Same author

Implementation of institutional thrombophilia guidelines and electronic medical record tools to reduce inpatient thrombophilia testing and costs.

Thrombosis research·2026
Same author

A novel approach to defining progression in MDS and precursor myeloid conditions in the MDS Natural History Study.

Blood advances·2026
Same author

Multiorgan Peripheral T-Cell Lymphoma Presenting as Isolated Cardiomyopathy.

JACC. Case reports·2025
Same author

Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same journal

Clinical Trials and Translational Advances in Metabolic Targeting.

Cancer treatment and research·2026
Same journal

Tools and Technologies for Studying Cancer Metabolism.

Cancer treatment and research·2026
Same journal

Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.

Cancer treatment and research·2026
Same journal

Biomarkers of Cancer Metabolism and Therapeutic Response.

Cancer treatment and research·2026
Same journal

Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.

Cancer treatment and research·2026
Same journal

Metabolic Reprogramming in Cancer Stem Cells.

Cancer treatment and research·2026
See all related articles

Related Experiment Video

Updated: Apr 17, 2026

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
12:58

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

9.9K

Post-transplant lymphoproliferative disorders.

Arun K Singavi1, Alexandra M Harrington, Timothy S Fenske

  • 1Department of Internal Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.

Cancer Treatment and Research
|February 7, 2015
PubMed
Summary
This summary is machine-generated.

Post-transplant lymphoproliferative disorders (PTLD) are serious complications after transplantation. Treatment strategies are evolving, with immune suppression reduction and rituximab showing promise, alongside novel therapies under investigation.

More Related Videos

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

1.5K
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.8K

Related Experiment Videos

Last Updated: Apr 17, 2026

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
12:58

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

9.9K
Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

1.5K
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.8K

Area of Science:

  • Transplantation immunology
  • Hematology
  • Oncology

Background:

  • Post-transplant lymphoproliferative disorders (PTLD) are significant complications following solid organ or stem cell transplantation.
  • Risk factors include Epstein-Barr virus (EBV) infection, recipient characteristics, and immunosuppression type.
  • EBV-positive PTLD involves uncontrolled B-cell proliferation, while EBV-negative PTLD may resemble non-Hodgkin's lymphoma.

Purpose of the Study:

  • To review the classification, risk factors, and current treatment strategies for PTLD.
  • To highlight emerging therapeutic approaches for PTLD management.
  • To discuss the need for established treatment guidelines.

Main Methods:

  • Literature review of PTLD classification and treatment.
  • Analysis of risk factors associated with PTLD development.
  • Evaluation of current and novel therapeutic interventions.

Main Results:

  • PTLD is classified by the WHO into four categories.
  • Immune suppression reduction (ISR) is a primary treatment, with early rituximab showing potential.
  • Sequential rituximab and chemotherapy demonstrate promising results for aggressive PTLD.

Conclusions:

  • Established treatment guidelines for PTLD are lacking.
  • Sequential therapy with rituximab and chemotherapy may become a standard of care.
  • Novel therapies require further investigation for PTLD prevention and treatment.